Sun-Taro Merger Nearing Completion As Shareholders Vote Yes

Sun Pharma Shares Thoughts On Generic GLP-1s, Mohali Plant, And FY2024 Results

Sun Pharma will finally merge with Taro as a single company, after failed attempts to absorb the firm over a decade ago. Also, the firm hints about its upcoming generic portfolio, including GLP-1 products, as well as increasing investment into its specialty business.

Shaking hands illustration
• Source: Shutterstock

The countdown begins. The long-awaited merger between Sun Pharma and Taro Pharmaceutical is expected to be completed over the next month, as the latter’s shareholders approved the agreement by an affirmative vote.

More from Deals

More from Business